1478
A. Nodzewska et al.
PAPER
N-Alkylation of Secondary Amines: (R)-N-Benzhydryl-1-
phenylethylamine Hydrochloride [(R)-3·HCl);27 Typical Proce-
dure
13C NMR (50 MHz, CDCl3): δ = 173.4, 143.03, 143.02, 138.0,
128.6, 128.5, 128.4, 128.0, 127.44, 127.37, 127.31, 127.2, 127.1,
64.2, 62.7, 52.0.
Anhydrous K2CO3 (3.04 g, 22.0 mmol) was added to a mixture of
(R)-(+)-α-methylbenzylamine (6; 6.45 mL, 6.06 g, 50.0 mmol) and
benzhydryl chloride (11.6 mL, 13.2 g, 65.0 mmol). The suspension
was heated at 140 °C for 18 h, and then poured into EtOH (1 L) and
H2O (150 mL). The mixture was loaded on activated Dowex-
50WX2 (ion-exchange resin), washed with MeOH (300 mL) and
EtOAc (100 mL), and then eluted with MeOH–NH3·H2O (9:1) until
no product was observable by TLC (eluent: MeOH–CH2Cl2 sat.
with NH3, 5.95). Collected ammonia solutions were concentrated.
Then 10% aq HCl (4.5 mL) was added to the crude product, and
H2O was evaporated in vacuo. The product was crystallized from a
mixture of EtOH and EtOAc to give (R)-3·HCl as a white solid;
yield: 12.6 g (78%); mp 203–204 °C; [α]D20 –99.0 (c 1.10, CHCl3).
Enantioselective Deprotonation Using Amine Hydrochloride
Followed by Aldol Reaction; (–)-(1R,2S,5S)-8-Benzyl-2-[(R)-(4-
fluorophenyl)(hydroxy)methyl]-8-azabicyclo[3.2.1]octan-3-one
[(–)-exo,anti-16c]; Typical Procedure
To a cooled (0 °C) solution of chiral (R)-3·HCl (0.517 g, 1.60
mmol, 1.05 equiv) in THF (4 mL) was added a solution of n-BuLi
in hexane (1.28 mL, 2.50 M, 3.19 mmol, 2.1 equiv) in THF (2 mL).
The mixture was stirred for 50 min, cooled to –78 °C and a solution
of N-benzylnortropinone (13; 0.327 g, 1.52 mmol, 1 equiv) in THF
(2 mL) was added dropwise. After stirring for 1 h, 4-fluorobenzal-
dehyde (0.208 g, 1.67 mmol, 1.1 equiv) was added. The mixture
was stirred for another 10 min, and then the reaction was quenched
with aq NH4Cl (10 mL), and extracted with CH2Cl2 (3 × 12 mL).
The combined extracts were dried (Na2SO4) and concentrated under
vacuum. Precipitation from a mixture of CH2Cl2–hexane gave
exo,anti-16c; yield: 0.454 g (88%); 96% ee [1H NMR in the pres-
ence of (R)-TFAE]; white solid; mp 110–111 °C; 99% ee after re-
IR (KBr): 3375, 2937, 2784, 1577, 1457 cm–1.
1H NMR (400 MHz, CDCl3): δ = 10.66 (t, J = 11.0 Hz, 1 H,
NH·HCl), 10.43 (t, J = 11.0 Hz, 1 H, NH·HCl), 7.72–7.05 (m, 15 H,
ArH), 4.73 [d, J = 9.4 Hz, 1 H, CH(Ph)2], 4.07–3.96 (m, 1 H,
CHMe), 1.36 (d, J = 6.9 Hz, 3 H, CH3).
13C NMR (100 MHz, CDCl3): δ = 136.2, 134.6, 133.8, 133.0, 129.2,
129.1, 129.0, 128.7, 128.64, 128.59, 128.5, 128.4, 64.6, 58.6, 20.0.
20
crystallization; [α]D –33.8 (c 0.65, MeOH); Rf = 0.5 (hexanes–
EtOAc–Et3N, 72:18:10).
IR (CHCl3): 3011, 2962, 1712, 1607, 1511, 1069 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.48–7.32 (m, 5 H, ArH), 7.20–
7.11 (m, 2 H, ArH), 6.90–6.70 (m, 2 H, ArH), 5.07 [d, J = 2.9 Hz, 1
H, CH(OH)Ph], 3.75–3.66 (m, 3 H, NCH2Ph, NCH, C1), 3.63–3.55
(m, 1 H, NCH, C5), 2.79 [ddd, J = 15.9, 4.7, 1.8 Hz, 1 H, ax-
CH(H)CO], 2.40 [d, J = 2.2 Hz, 1 H, CHCH(OH)Ar], 2.38–2.15 [m,
3 H, eq-CH(H)CO, CH(H) (C6, C7)], 1.75–1.52 [m, 2 H, CH(H)
(C6, C7)].
(R)-N-Benzhydryl-1-phenyl-2-(piperidin-1-yl)ethanamine
[(R)-10]
Isolated from 10·HCl solution by extraction; yield: 1.48 g (80%,
20
5 mmol scale); yellow oil; [α]D –76.6 (c 0.70, CHCl3); Rf = 0.7
(MeOH–CH2Cl2, 1:9).
IR (CHCl3): 3291, 2938, 1493, 1453, 909 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.48–7.11 (m, 15 H, ArH), 4.62
[s, 1 H, CH(Ph)2], 3.66 (dd, J = 11.2, 3.2 Hz, 1 H, NHCHCH2), 2.52
[t, J = 11.7 Hz, 1 H, PhCHCH(H)N], 2.35–2.22 (m, 2 H, CH of pi-
peridine ring), 2.22–2.18 [m, 3 H, PhCHCH(H)N, CH of piperidine
ring], 1.64–1.48 (m, 4 H, piperidine CH2), 1.48–1.32 (m, 2 H, piper-
idine CH2).
13C NMR (100 MHz, CDCl3): δ = 144.8, 143.9, 143.1, 128.3, 128.2,
128.0, 127.9, 127.7, 127.5, 127.1, 126.8, 126.4, 66.4, 62.7, 56.5,
54.5, 26.1, 24.4.
13C NMR (100 MHz, CDCl3): δ = 208.2, 161.9 (d, 1JC,F = 243 Hz),
4
137.5, 137.4 (d, JC,F = 3 Hz), 129.0, 128.8, 127.8, 127.1 (d,
3JC,F = 8 Hz), 114.8 (d, 2JC,F = 21 Hz), 75.9, 65.0, 64.4, 58.9, 57.0,
51.6, 26.8, 26.4.
HRMS-ESI: m/z [M + H]+ calcd for C21H23FNO2: 340.1713; found:
340.1708.
(+)-(1R,2S,5S)-8-Benzyl-2-{(R)-hydroxy[4-(trifluorometh-
yl)phenyl]methyl}-8-azabicyclo[3.2.1]octan-3-one [(+)-exo,anti-
16d]
HRMS-ESI: m/z [M + H]+ calcd for C26H31N2: 371.2487; found:
371.2473.
20
Yield: 0.526 g (90%); white solid; mp 120–122 °C; 80% ee; [α]D
+1.8 (c 1.15, CHCl3); Rf = 0.5 (hexanes–EtOAc–Et3N, 72:18:10).
(R)-N-Benzhydryl-2-(4-methylpiperazin-1-yl)-1-phenylethan-
amine [(R)-11]
1H NMR (400 MHz, CDCl3): δ = 7.54 (d, J = 8.3 Hz, 2 H, ArH),
7.48–7.32 (m, 5 H, ArH), 7.31 (d, J = 8.4 Hz, 2 H, ArH), 5.13 [d,
J = 2.5 Hz, 1 H, CH(OH)Ph], 3.77–3.66 (m, 3 H, NCH2Ph, NCH,
C1), 3.63–3.57 (m, 1 H, NCH, C5), 2.79 [ddd, J = 16.0, 4.7, 1.9 Hz,
1 H, ax-CH(H)CO], 2.45 [d, J = 2.0 Hz, 1 H, CHCH(OH)Ar], 2.40–
2.18 [m, 3 H, eq-CH(H)CO, CH(H) (C6, C7)], 1.76–1.59 [m, 2 H,
CH(H) (C6, C7)].
Isolated from 11·HCl solution by extraction; yield: 1.56 g (81%,
20
5 mmol scale); yellow oil; [α]D –80.2 (c 0.85, CHCl3); Rf = 0.5
(MeOH–CH2Cl2, 1:9).
IR (CHCl3): 3294, 2943, 2804, 1455, 1165, 909 cm–1.
1H NMR (400 MHz, CDCl3): δ = 7.49–7.42 (m, 2 H, ArH), 7.41–
7.17 (m, 13 H, ArH), 4.62 [s, 1 H, CH(Ph)2], 3.65 (dd, J = 11.2, 3.2
Hz, 1 H, NHCHCH2), 3.28 (br s, 1 H, NH), 2.52 [t, J = 11.9 Hz, 1
H, PhCHCH(H)N], 2.65–2.15 (m, 8 H, CH of piperazine ring), 2.33
(s, 3 H, CH3), 2.65 [dd, J = 12.3 Hz, 3.3 Hz, 1 H, PhCHCH(H)N].
13C NMR (100 MHz, CDCl3): δ = 207.8, 145.6, 137.4, 129.3 (q,
3
2JC,F = 32 Hz), 129.1, 128.9, 127.9, 125.9, 125.0 (q, JC,F = 4 Hz),
1
124.2 (q, JC,F = 272 Hz), 76.0, 65.1, 63.9, 59.0, 57.0, 51.6, 26.9,
26.5.
HRMS-ESI: m/z [M + H]+ calcd for C22H23F3NO2: 390.1681; found:
390.1684.
13C NMR (100 MHz, CDCl3): δ = 144.5, 143.9, 142.6, 128.33,
128.25, 128.0, 127.9, 127.6, 127.4, 127.1, 126.9, 126.4.
HRMS-ESI: m/z [M + H]+ calcd for C26H32N3: 386.2596; found:
386.2589.
(+)-(1R,2S,5S)-9-Benzyl-2-[(R)-(4-bromophenyl)(hy-
droxy)methyl]-9-azabicyclo[3.3.1]nonan-3-one [(+)-exo,anti-
18b]
Methyl rac-2-(Benzhydrylamino)-2-phenylacetate (12)28
Isolated from 12·HCl solution by extraction; yield: 0.862 g (52%,
5 mmol scale); yellow oil; Rf = 0.43 (hexanes–EtOAc, 85:15).
IR (CHCl3): 3339, 3065, 1735, 1494, 1454, 1173 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.46–7.18 (m, 15 H, ArH), 4.75
[s, 1 H, CH(Ph)2], 4.36 (s, 1 H, CHCO2Me), 3.68 (s, 3 H, CH3).
20
Yield: 0.466 g (75%); white solid; mp 124–125 °C; 72% ee; [α]D
+7.1 (c 0.60, CHCl3); Rf = 0.37 (hexanes–EtOAc–Et3N, 72:18:10).
1H NMR (400 MHz, CDCl3): δ = 7.35–7.48 (m, 7 H, ArH), 7.07 (d,
J = 8.4 Hz, 2 H, ArH), 6.98 (br s, 1 H, OH), 5.10 [d, J = 3.6 Hz, 1
H, CH(OH)Ph], 4.08 (d, J = 12.8 Hz, 1 H, NCH2Ph), 4.04 (d,
J = 12.8 Hz, 1 H, NCH2Ph), 3.43 (d, J = 3.5 Hz, 1 H, NCH, C1),
3.37 (br s, 1 H, NCH, C5), 2.87 [dd, J = 16.4 Hz, J = 7.0 Hz, 1 H,
Synthesis 2014, 46, 1475–1480
© Georg Thieme Verlag Stuttgart · New York